Jatuporn Sujjitjoon - Mahidol University

View Scopus Profile

Emailjatuporn.sujmahidol.acth

h-index
h5-index

Research activity per year

Education/Academic qualification

Chulalongkorn University Bangkok, Thailand

Master, Department of Immunology, Faculty of Medicine Siriraj Hospital

PhD, Department of Immunology, Faculty of Medicine Siriraj Hospital

Keywords

Q Science (General)
Immunology
Biotechnology
Genetic engineering
Immunotherapy
Chimeric antigen receptor T cells
RM Therapeutics. Pharmacology
Immunotherapy
Cellular immunotherapy
Drug development
Solid tumor

Self-Identified Research Cluster

Health Science
Science and Technology

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

SDG 3 Good Health and Well-being
SDG 9 Industry, Innovation, and Infrastructure
SDG 17 Partnerships for the Goals

Fingerprint

Dive into the research topics where Jatuporn Sujjitjoon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

35 Article
1 Comment/debate

B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma
Sujjitjoon, J., Ng, W. L., Kongkla, K., Jarutatsanangkoon, K., Chongsutakawewong, K., Subhadhirasakul, S., Uiprasertkul, M., Udompunturak, S., Junking, M., Yenchitsomanus, P. T. & Atchaneeyasakul, L. O., Dec 2026, In: Scientific Reports. 16, 1, 4210.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Citations (Scopus)
Enhanced antitumor efficacy of next-generation B7-H3 chimeric antigen receptor T cells containing CD28, CD137 and CD27 costimulatory domains in multiple myeloma
Natungnuy, K., Luangwattananun, P., Supimon, K., Yuti, P., Rujirachaivej, P., Sujjitjoon, J., Junking, M., Okada, S. & Yenchitsomanus, P. T., Mar 2026, In: Cytotherapy. 28, 3, 102014.
Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Harnessing a bispecific αGD2 × αCD3 protein engager to target GD2-overexpressing lung tumors
Sawasdee, N., Panya, A., Sujjitjoon, J., Yenchitsomanus, P. T. & Thepmalee, C., Dec 2026, In: Scientific Reports. 16, 1, 12920.
Research output: Contribution to journal › Article › peer-review

Open Access
Intravitreal GD2-Specific Chimeric Antigen Receptor T-Cell Therapy for Refractory Retinoblastoma
Subhadhirasakul, S., Sujjitjoon, J., Yenchitsomanus, P. T., Jarutatsanangkoon, K., Loon, N. W., Sanpakit, K., Buaboonnam, J., Takpradit, C., Yuti, P., Sawasdee, N., Luangwattananun, P., Sangkitporn, S., Limmahachai, A. & Atchaneeyasakul, L. O., Jul 2026, In: Pediatric Blood and Cancer. 73, 7, e70334.
Research output: Contribution to journal › Article › peer-review

Open Access
Triple-costimulatory GD2-CAR T cells incorporating CD28, 4-1BB and CD27 mediate potent cytotoxicity and reduce exhaustion in solid tumour models
Sujjitjoon, J., Kongkla, K., Yuti, P., Sawasdee, N., Natungnuy, K., Poungvarin, N. & Yenchitsomanus, P.-T., 1 Sept 2026, (E-pub ahead of print) In: Biomedicine and Pharmacotherapy. 203, p. 119897
Research output: Contribution to journal › Article › peer-review